Profil
Christopher Jordan worked as Vice President-Regulatory Affairs at Endocyte, Inc. from 2018 to 2019.
He completed his graduate degree at George Washington University and his undergraduate degree at Purdue University.
Anciens postes connus de Christopher Jordan
| Sociétés | Poste | Fin |
|---|---|---|
| ENDOCYTE, INC. | Conseiller Juridique Général | 01/12/2019 |
Formation de Christopher Jordan
| Purdue University | Undergraduate Degree |
| George Washington University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
